Reference

1. McGuffin M, Hobbs C, Upton R, Goldberg A, eds (1997). American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press.
2. Nesher, M., Spolansky, U., Rosen, H. and Lichtstein, D(2007). The endogenous digitalis- like compounds -A new family of steroid hormones. Life Sci. Vol.80:2093- 2107.
3. Shumaik GM, Wu AW, Ping AC (1988). Oleander poisoning: treatment with digoxin-specific Fab antibody fragments. Ann Emerg Med. Vol.17:732-735.
4. Schoner, W (2002). Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem Vol.269:2440-2448.
5. Schoner, W., Bauer, N., Muller-Ehmsen, J., Kramer, U., Hambarchian, N., Schwinger, R., Moeller, H., Kost, H., Weitkamp, C., Schweitzer, T., Kirch, U., Neu, H., Grunbaum, E.G (2003). Ouabain as a mammalian hormone. Ann N Y Acad Sci. Vol.986:678-684. 
6. Schoner, W. and Scheiner-Bobis, G (2007). Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs. Vol.7:173-189.
7. Dick M, Curwin J, Tepper D (1991). Digitalis intoxication recognition and management. J Clin Pharmacol .Vol.31:444-447.
8. Hood WB, Dans A, Guyatt GH, Jaeschke R, McMurray JJ(2004). Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database Syst Rev (2):CD002901.
9. Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Cleason P(2001). Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs. Vol. 12:475-483.
10. Lopez-Lazaro M, Palma De La Pena N, Pastor N, et al(2003). Anti-tumour activity of Digitalis purpurea L. subsp.heywoodii. Planta Med .Vol.69:701-704.
11. Lindholm P, Gullbo J, Claeson P, et al(2002). Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts. J Biomol Screen . Vol.7:333-340.
12. Lacassie E, Marquet P, Martin-Dupont S, Gaulier JM, Lachatre G(2000). A non-fatal case of intoxication with foxglove, documented by means of liquid chromatography-electrospray-mass-spectrometry. J Forensic Sci .Vol.45:1154-1158.
13. Bagrov, A.Y., Fedorova, O.V (2005). Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Front Biosci Vol.10: 2250-2256. 
14. Buckalew, V.M (2005). Endogenous digitalis-like factors. An historical overview. Front Biosci 1,Vol.0:2325-2334.
15. Blaustein, M.P., Zhang, J., Chen, L., Hamilton, B.P (2006). How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol; Vol.290:R514-R523.
16. Dec GW (2003). Digoxin remains useful in the management of chronic heart failure. Med Clin North Am .Vol.87:317
17. Tatro DS, ed. Drug Interaction Facts. St. Louis, MO(2002): Wolters Kluwer Health, Inc.; 2004. Jowett N. Foxglove poisoning. Hosp Med.Vol.63:758-759.
18. Wickersham RM, Novak K (2004), managing eds. Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons
19. Meyer JE (2002). The Herbalist. Hammond, IN: Hammond Book Co; 1934: 96.Belcastro PF. Digitalis: from folklore remedy to valuable drug. J Am Pharm Assoc.Vol. 42:857.